Close Menu

This article has been updated with new information about Yourgene's stock offering.

NEW YORK – Yourgene Health said on Tuesday that it has agreed to acquire Coastal Genomics, a sample prep technology company based in Vancouver, British Columbia, for up to $13.5 million.

Yourgene plans to pay an initial $3 million in cash and $2.5 million in equity, and a contingent consideration of up to $8 million in cash and equity.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.